-+ 0.00%
-+ 0.00%
-+ 0.00%

ASCENDIS PHARMA A/S - TO REGAIN EXCLUSIVE RIGHTS TO TRANSCON TECHNOLOGY IN METABOLIC AND CARDIOVASCULAR DISEASES

Reuters·09/14/2026 22:01:43

Please log in to view news